Search Press releases Keywords From To 5 Dec 2011 Long-term use of antiepileptic drug Vimpat® (lacosamide) reduced seizure frequency and severity and improved health-related quality of life measures Read More 30 Nov 2011 New data on Vimpat® (lacosamide) to be presented at the 65th Annual Meeting of the American Epilepsy Society Read More 22 Nov 2011 UCB acquires Lectus Therapeutics’ key pharmaceutical assets Read More 15 Nov 2011 UCB enters into strategic partnerships in clinical development with PAREXEL and PRA Read More 8 Nov 2011 Epratuzumab phase IIb data demonstrated sensitivity of BICLA, a novel BILAG-based composite endpoint Read More 8 Nov 2011 New data for Cimzia® (certolizumab pegol) showed a rapid and sustained response in Japanese rheumatoid arthritis (RA) patients unresponsive to or unable to take methotrexate (MTX) therapy Read More Pagination First page Previous page Previous … Page 134 Page 135 Page 136 Page 137 Current page 138 Page 139 Page 140 Page 141 Page 142 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
